Innovations that advance healthcare and achieve social impact
Improving the lives of patients and impacting the healthcare of millions through translating world-class research into high performance diagnostic tests.
Introducing our flagship product IRISA-TB™, an innovative new assay for the faster, simpler diagnosis of extra-pulmonary tuberculosis (EPTB).
Groundbreaking products that have a lasting impact on how we diagnose and control disease
IRISA-TB™
Rapid testing for pleural TB and other forms of extra-pulmonary tuberculosis
News and Publications
Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting
Pleural tuberculosis (TB) remains difficult to diagnose. Tests measuring host biomarkers, such as adenosine deaminase (ADA) and unstimulated interferon-gamma, perform better than conventional microbiological tests for TB diagnosis using pleural […]
Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
The diagnosis of pleural tuberculosis (TB) is problematic. The comparative performance of newer same-day tools for pleural TB, including Xpert MTB/RIF Ultra (ULTRA), has hitherto not been comprehensively studied. Adenosine […]
Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: A prospective cohort study
The accuracy of currently available same-day diagnostic tools (smear microscopy and conventional nucleic acid amplification tests) for pleural tuberculosis (TB) is sub-optimal. Newer technologies may offer improved detection. The usefulness […]